Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1946851000168118 | prilocaine hydrochloride 50 mg / 5 mL injection, 5 mL ampoule (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1946861000168116 | prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | Is a | prilocaine | true | Inferred relationship | Some | ||
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 960759065 | |
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | has intended active ingredient | prilocaine | true | Inferred relationship | Some | 960759064 | |
prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | has Australian BoSS | prilocaine hydrochloride | true | Inferred relationship | Some | 960759064 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Citanest 1% (50 mg/5 mL) injection, 5 mL ampoule | Is a | True | prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | Inferred relationship | Some | |
prilocaine hydrochloride 50 mg / 5 mL injection, 10 x 5 mL ampoules (medicinal product pack) | has MPUU | True | prilocaine hydrochloride 1% (50 mg/5 mL) injection, ampoule | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set